These results implied that tumor-derived IL-6 simulated the amplification and recruitment of immature CD11b+Gr-1−F4/80−MHC-II− e-MDSCs instead of the conventional CD11b+Gr-1+ MDSCs exclusively in tumor tissues. The gene discussed is ITGAM; the disease is neoplasm.